Biotech · Private company
PeptiDream Inc.
Track this companyFree. Adds PeptiDream Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- PA-001Phase 1 · COVID - 19ClinicalTrials.gov · fetched Nov 12, 2026
- PD-32766D (a Copper-64 [64Cu] labeled peptide)Phase 1 · Clear Cell Renal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- PD-32766T (an Actinium-225 [225Ac] labeled peptide)Phase 1 · Clear Cell Renal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Study of Theranostic Pair PD-32766D/T in Participants With Carbonic Anhydrase IX Positive Clear Cell Renal Cell CarcinomaPHASE1 · RECRUITING · started Jul 7, 2026ClinicalTrials.gov NCT07688187 · fetched Nov 12, 2026
- PA-001 Ph.1 Study in Healthy and Elderly SubjectsPHASE1 · COMPLETED · started Jul 30, 2024ClinicalTrials.gov NCT07518771 · fetched Nov 12, 2026